Risk factor, pattern, etiology and outcome in ischemic stroke patients with cancer: A nested case-control study

Cerebrovascular Diseases

Volumn 23, Issue 2-3, 2007, Pages 181-187

  Zhang, Yun Yun ^a,d   Cordato, Dennis ^a   Shen, Qing ^a   Sheng, Ai Zhen ^a   Hung, Wai Tak ^c   Chan, Daniel K Y ^a,b  

^a BANKSTOWN LIDCOMBE HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c State Coordination Unit   (Australia)

^d Shanghai Yueyang Hospital of Chinese and Western Medicine   (China)

Author keywords

Cancer, risk factor; Ischemic stroke

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; HEPARIN; TICLOPIDINE; WARFARIN;

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER; CANCER PATIENT; CAUSAL ATTRIBUTION; CEREBROVASCULAR ACCIDENT; COLON CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DEPRESSION; DISEASE PREDISPOSITION; FEMALE; GROUPS BY AGE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; LUNG CANCER; LUNG EMBOLISM; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; MORTALITY; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BLOOD COAGULATION; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; DEPRESSION; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MYOCARDIAL INFARCTION; NEOPLASMS; NEW SOUTH WALES; PULMONARY EMBOLISM; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 33846913898     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097639     Document Type: Article

References (26)

1. Cestari DM, Weine DM, Panageas KS, Segal AZ, De Angelis LM: Stroke in patients with cancer: incidence and etiology. Neurology 2004;62:2025-2030.
2. Amico L, Caplan LR, Thomas C: Cerebrovascular complications of mucinous cancers. Neurology 1989;39:522-526.
3. Packer RJ, Rorke LB, Lange BJ, Siegel KR, Evans AE: Cerebrovascular accidents in children with cancer. Pediatrics 1985;76:194-201.
4. O'Neill BP, Dinapoli RP, Okazaki H: Cerebral infarction as a result of tumor emboli. Cancer 1987;60:90-95.
5. Lefkovitz NW, Roessmann U, Kori SH: Major cerebral infarction from tumor embolus. Stroke 1986;17:555-557.
6. Rogers LR: Cerebrovascular complications in cancer patients. Neurol Clin 2003;21:167-192.
7. Graus F, Rogers LR, Posner JB: Cerebrovascular complications in patients with cancer. Medicine 1985;64:16-35.
8. Nilsson G, Holmberg L, Garmo H, Terent A, Blomqvist C: Increased incidence of stroke in women with breast cancer. Eur J Cancer 2005;41:423-429.
9. Sudlow CL, Warlow CP: Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence. Stroke 1997;28:491-499.
10. Kitamura A, Iso H, Iida M, Naito Y, Sato S, Jacobs DR, Nakamura M, Shimamoto T, Komachi Y: Trends in the incidence of coronary heart disease and stroke and the prevalence of cardiovascular risk factors among Japanese men from 1963 to 1994. Am J Med 2002;112:104-109.
11. Intiso D, Stampatore P, Zarrelli MM, Guerra GL, Arpaia G, Simone P, Tonali P, Beghi E: Incidence of first-ever ischemic and hemorrhagic stroke in a well-defined community of southern Italy, 1993-1995. Eur J Neurol 2003;10:559-565.
12. Graus F, Rogers LR, Posner JB: Cerebrovascular complications in patients with cancer. Medicine 1985;64:16-35.
13. Chaturvedi S, Ansell J, Recht L: Should cerebral ischemic events in cancer patients be considered a manifestation of hypercoagulability? Stroke 1994;25:1215-1218.
14. The International Statistical Classification of Diseases and Related Health Problems, rev 10, Australian modification (ICD-10-AM). Sydney, National Centre for Classification in Health, 2004.
15. Lai SM, Duncan PW: Stroke recovery profile and the modified Rankin assessment. Neuroepidemiology 2001;20:26-30.
16. Adams HP Jr, Bendixen BH, Kappelle LJ: Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
17. Selvin S: Modern Applied Biostatistical Methods Using S-Plus. Oxford, Oxford University Press, 1998, pp 328-330.
18. Maxwell AE: Comparing the classification of subjects by two independent judges. Br J Psychiatry 1970;116:651-655.
19. Arakawa M, Miyake Y, Taira K: Hypertension and stroke in centenarians, Okinawa, Japan. Cerebrovasc Dis 2005;20:233-238.
20. Melnik TA, Hosler AS, Sekhobo JP, Duffy TP, Tierney EF, Engelgau MM, Geiss LS: Diabetes prevalence among Puerto Rican adults in New York City, NY, 2000. Am J Public Health 2004;94:434-437.
21. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, D'Agostino RB, Massaro JM, Beiser A, Wolf PA, Benjamin EJ: Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004;110:1042-1046.
22. Shen Q, Cordato DJ, Chan DK, Kokkinos J: Comparison of stroke risk factors and outcomes in patients with English-speaking background versus non-English-speaking background. Neuroepidemiology 2005;24:79-86.
23. Joffee II, Jacobs LE, Owen AN, Ioli A, Kotler MN: Noninfective valvular masses: review of the literature with emphasis on imaging techniques and management. Am Heart J 1996;131:1175-1183.
24. Wojtukiewicz MZ, Sierko E, Zacharski LR, Zimnoch L, Kudryk B, Kisiel W: Tissue factor-dependent coagulation activation and impaired fibrinolysis in situ in gastric cancer. Semin Thromb Hemost 2003;329:291-300.
25. Kohli M, Kaushal V, Mehta P: Role of coagulation and fibrinolytic system in prostate cancer. Semin Thromb Hemost 2003;329:301-308.
26. Caine GJ, Stonelake PS, Lip GY, Kehoe ST: The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia 2002;4:465-473.